Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.

[1]  A. Divani,et al.  Intra‐Arterial Thrombolysis for Central Retinal Artery Occlusion in United States: Nationwide In‐Patient Survey 2001‐2003 , 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[2]  N. Newman,et al.  Thrombolysis for central retinal artery occlusion. , 2007, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[3]  S. Hayreh.  Comment re: multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  J. Garcia-Arumi,et al.  Surgical embolus removal in retinal artery occlusion , 2006, British Journal of Ophthalmology.

[5]  H. Mattle,et al.  Therapy of Basilar Artery Occlusion: A Systematic Analysis Comparing Intra-Arterial and Intravenous Thrombolysis , 2006, Stroke.

[6]  C. Schmoor,et al.  Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no. 1 , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[7]  V. Biousse,et al.  Transient monocular visual loss. , 2005, American journal of ophthalmology.

[8]  H. Tillmanns,et al.  Treatment of acute central retinal artery occlusionwith the platelet glycoprotein IIb/IIIa receptor inhibitor tirofiban. , 2005, Thrombosis and haemostasis.

[9]  F. Miller,et al.  Calcific retinal embolism as an indicator of severe unrecognised cardiovascular disease , 2005, Heart.

[10]  N. Pfeiffer,et al.  [Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion. A case study]. , 2005, Deutsche medizinische Wochenschrift.

[11]  G. Schroth,et al.  Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  C. Cannon,et al.  Thrombolysis and adjunctive therapy in acute myocardial infarction: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[13]  S. Hayreh,et al.  Central retinal artery occlusion. Retinal survival time. , 2004, Experimental eye research.

[14]  M. Reynard,et al.  Neodymium:yttrium-aluminum-garnet laser arteriotomy with embolectomy for central retinal artery occlusion. , 2004, American journal of ophthalmology.

[15]  A. Wakhloo,et al.  Intra-arterial fibrinolytic therapy in central retinal artery occlusion , 2004, Neuroradiology.

[16]  M. Strotzer,et al.  Selective intraarterial fibrinolysis of acute central retinal artery occlusion. , 2003, Acta radiologica.

[17]  A. Kampik,et al.  Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion. , 2003, Archives of ophthalmology.

[18]  C. Reddy,et al.  Screening for Retinopathy of Prematurity Using Wide-Field Digital Retinal Imaging: Sensitivity and Specificity , 2002 .

[19]  J. Schulte‐Mönting,et al.  Prognosis of central retinal artery occlusion: local intraarterial fibrinolysis versus conservative treatment. , 2002, AJNR. American journal of neuroradiology.

[20]  S. Beatty,et al.  Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data , 2000, The British journal of ophthalmology.

[21]  U. Rehany,et al.  Aggressive systematic treatment for central retinal artery occlusion. , 1999, American journal of ophthalmology.

[22]  Joseph P. Broderick,et al.  Effects of tissue plasminogen activator for acute ischemic stroke at one year , 1999 .

[23]  H. Zeumer,et al.  Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator. , 1999, Ophthalmology.

[24]  I. Scharrer,et al.  Fibrinolytic Therapy with Low-Dose Recombinant Tissue Plasminogen Activator in Retinal Vein Occlusion , 1998, Ophthalmologica.

[25]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[26]  C. Greven,et al.  Retinal arterial occlusions in young adults. , 1995, American journal of ophthalmology.

[27]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[28]  Gusto Angiographic Investigators.  The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.

[29]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[30]  J. Marler,et al.  Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.

[31]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[32]  A. Wakhloo,et al.  Microcatheter urokinase infusion in central retinal artery occlusion. , 1992, American journal of ophthalmology.

[33]  J. Gore,et al.  Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis. , 1992, The American journal of cardiology.

[34]  T. Pryor,et al.  Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. , 1991, The American journal of cardiology.

[35]  M. Reim,et al.  Lysebehandlung bei retinalen Arterienverschlüssen mit Plasminogen-Aktivator , 1991 .

[36]  P. Maguire,et al.  Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi. , 1988, American journal of ophthalmology.

[37]  J. Augsburger,et al.  Visual prognosis following treatment of acute central retinal artery obstruction. , 1980, The British journal of ophthalmology.